PI3K and ERK signaling pathways are involved in differentiation of monocytic cells induced by 27-hydroxycholesterol
27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by st...
Saved in:
Published in | The Korean journal of physiology & pharmacology Vol. 21; no. 3; pp. 301 - 308 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Physiological Society and The Korean Society of Pharmacology
01.05.2017
대한약리학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1226-4512 2093-3827 |
DOI | 10.4196/kjpp.2017.21.3.301 |
Cover
Loading…
Abstract | 27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors. Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol. |
---|---|
AbstractList | 27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation.
Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors.
Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol. KCI Citation Count: 3 27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors. Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol. 27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors. Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol.27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors. Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol. |
Author | Kim, Koanhoi Kim, Bo-Young Park, Young Chul Cho, Hyok-rae Son, Yonghae Eo, Seong-Kug |
AuthorAffiliation | 1 Department of Pharmacology, Pusan National University School of Medicine, Yangsan 50612, Korea 5 Department of Neurosurgery, Kosin University College of Medicine, Busan 49267, Korea 4 Institute of Marine BioTechnology, Pusan National University, Busan 46241, Korea 2 Department of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea 3 College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, Korea |
AuthorAffiliation_xml | – name: 4 Institute of Marine BioTechnology, Pusan National University, Busan 46241, Korea – name: 2 Department of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea – name: 5 Department of Neurosurgery, Kosin University College of Medicine, Busan 49267, Korea – name: 1 Department of Pharmacology, Pusan National University School of Medicine, Yangsan 50612, Korea – name: 3 College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, Korea |
Author_xml | – sequence: 1 givenname: Yonghae surname: Son fullname: Son, Yonghae organization: Department of Pharmacology, Pusan National University School of Medicine, Yangsan 50612, Korea., Institute of Marine BioTechnology, Pusan National University, Busan 46241, Korea – sequence: 2 givenname: Bo-Young surname: Kim fullname: Kim, Bo-Young organization: Department of Pharmacology, Pusan National University School of Medicine, Yangsan 50612, Korea – sequence: 3 givenname: Young Chul surname: Park fullname: Park, Young Chul organization: Department of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea – sequence: 4 givenname: Seong-Kug surname: Eo fullname: Eo, Seong-Kug organization: College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, Korea – sequence: 5 givenname: Hyok-rae surname: Cho fullname: Cho, Hyok-rae organization: Department of Neurosurgery, Kosin University College of Medicine, Busan 49267, Korea – sequence: 6 givenname: Koanhoi surname: Kim fullname: Kim, Koanhoi organization: Department of Pharmacology, Pusan National University School of Medicine, Yangsan 50612, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28461772$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002217142$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kUtP3DAUha0KVAbKH-ii8rIskvqROPGmEkJARyBRIbq2HD9m3MnYqZ2ZNv8ezwxFbRddXUv-zrmPcwqOfPAGgPcYlRXm7NPq-zCUBOGmJLikJUX4DZgRxGlBW9IcgRkmhBVVjckJOE_JdQi1NapbxN-CE9JWDDcNmYH0dU7voPQaXj_eweQWXvbOL-Agx-VPOSUoo4HOb0O_NTo_oHbWmmj86OTogofBwnXwQU2jU1CZvk-Z0huV6W6CpCmWk47h16SWoTdpNDH078CxlX0y5y_1DHy7uX66-lLcP9zOry7vC1VRNhaSaq5rzE3Xtayl2GLELVdcVrwhHdNMY2pMRYxtELGIMYJIQyhliDPWUEXPwMXB10crVsqJIN2-LoJYRXH5-DQXmOZD1Dyznw_ssOnWRqu8YJS9GKJbyzjtlX__eLfMPltRV4hjzLLBxxeDGH5s8qZi7dLuHtKbsEkCt7yqCapqlNEPf_Z6bfI7lQyQA6BiSCka-4pgJHbpi136Ype-IFhQkdPPovYfkXLjPqM8r-v_J30GWfG2WQ |
CitedBy_id | crossref_primary_10_1016_j_jare_2019_02_005 crossref_primary_10_1097_FJC_0000000000000889 crossref_primary_10_1016_j_jsbmb_2022_106122 crossref_primary_10_3390_ijms23126361 crossref_primary_10_4196_kjpp_2024_28_2_107 crossref_primary_10_4110_in_2023_23_e40 crossref_primary_10_1016_j_intimp_2019_01_045 crossref_primary_10_1016_j_biopha_2019_109074 crossref_primary_10_4110_in_2020_20_e17 |
Cites_doi | 10.1016/S0021-9150(98)00196-8 10.1016/j.celrep.2013.10.006 10.4062/biomolther.2014.067 10.1016/j.freeradbiomed.2014.07.026 10.3389/fimmu.2013.00139 10.1002/eji.1830270213 10.1016/j.bbrc.2013.07.046 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C 10.1091/mbc.E11-12-0993 10.1073/pnas.97.23.12694 10.1016/j.bbrc.2013.11.052 10.1016/j.immuni.2008.08.006 10.1016/j.bbadis.2014.12.003 10.1016/j.cmet.2014.05.013 10.1038/labinvest.2010.94 10.1161/01.CIR.91.9.2488 10.1146/annurev.immunol.18.1.767 10.1128/MCB.05857-11 10.5551/jat.13.82 10.1016/j.taap.2013.12.007 10.4049/jimmunol.160.9.4587 10.1182/blood-2011-11-370130 10.1074/jbc.M113.524819 10.1161/CIRCULATIONAHA.107.699173 10.1016/j.freeradbiomed.2015.12.007 |
ContentType | Journal Article |
Copyright | Copyright © Korean J Physiol Pharmacol 2017 |
Copyright_xml | – notice: Copyright © Korean J Physiol Pharmacol 2017 |
DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
DOI | 10.4196/kjpp.2017.21.3.301 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 2093-3827 |
EndPage | 308 |
ExternalDocumentID | oai_kci_go_kr_ARTI_1361759 PMC5409116 28461772 10_4196_kjpp_2017_21_3_301 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; grantid: NRF-2013R1A1A4A01010144; NRF-2016R1C1B1013443 |
GroupedDBID | --- 5-W 53G 5GY 8JR 8XY 9ZL AAYXX ABDBF ACUHS ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK E3Z EBD EF. ESX F5P GX1 HYE KVFHK MK0 OK1 P2P P5Y P6G RPM TR2 TUS .UV NPM 7X8 5PM ABPTK ACYCR |
ID | FETCH-LOGICAL-c436t-a3d9d519ebb86831f109f9c9a4972b6d6d13ee42ef702f06620272336096673c3 |
ISSN | 1226-4512 |
IngestDate | Tue Nov 21 21:37:30 EST 2023 Thu Aug 21 13:58:10 EDT 2025 Thu Jul 10 22:46:06 EDT 2025 Thu Jan 02 22:25:53 EST 2025 Thu Apr 24 23:07:51 EDT 2025 Tue Jul 01 02:33:16 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Dendritic cells PI3K 27-hydroxycholesterol Differentiation ERK |
Language | English |
License | http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c436t-a3d9d519ebb86831f109f9c9a4972b6d6d13ee42ef702f06620272336096673c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000764.2017.21.3.002 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5409116 |
PMID | 28461772 |
PQID | 1894520450 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1361759 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5409116 proquest_miscellaneous_1894520450 pubmed_primary_28461772 crossref_primary_10_4196_kjpp_2017_21_3_301 crossref_citationtrail_10_4196_kjpp_2017_21_3_301 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-05-01 |
PublicationDateYYYYMMDD | 2017-05-01 |
PublicationDate_xml | – month: 05 year: 2017 text: 2017-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | The Korean journal of physiology & pharmacology |
PublicationTitleAlternate | Korean J Physiol Pharmacol |
PublicationYear | 2017 |
Publisher | The Korean Physiological Society and The Korean Society of Pharmacology 대한약리학회 |
Publisher_xml | – name: The Korean Physiological Society and The Korean Society of Pharmacology – name: 대한약리학회 |
References | Wu (10.4196/kjpp.2017.21.3.301_ref8) 2013; 5 van de Laar (10.4196/kjpp.2017.21.3.301_ref16) 2012; 119 Umetani (10.4196/kjpp.2017.21.3.301_ref7) 2014; 20 Son (10.4196/kjpp.2017.21.3.301_ref5) 2013; 438 Majmundar (10.4196/kjpp.2017.21.3.301_ref18) 2012; 32 So (10.4196/kjpp.2017.21.3.301_ref24) 2013; 4 Ma (10.4196/kjpp.2017.21.3.301_ref25) 2014; 289 Lee (10.4196/kjpp.2017.21.3.301_ref23) 2012; 23 Kim (10.4196/kjpp.2017.21.3.301_ref3) 2014; 274 Luther (10.4196/kjpp.2017.21.3.301_ref20) 2000; 97 Seo (10.4196/kjpp.2017.21.3.301_ref12) 2015; 23 Banchereau (10.4196/kjpp.2017.21.3.301_ref13) 2000; 18 Willimann (10.4196/kjpp.2017.21.3.301_ref19) 1998; 28 Alvarez (10.4196/kjpp.2017.21.3.301_ref21) 2008; 29 Vurusaner (10.4196/kjpp.2017.21.3.301_ref9) 2014; 77 Bobryshev (10.4196/kjpp.2017.21.3.301_ref17) 2010; 90 Vurusaner (10.4196/kjpp.2017.21.3.301_ref10) 2016; 91 Kim (10.4196/kjpp.2017.21.3.301_ref6) 2015; 1852 Palucka (10.4196/kjpp.2017.21.3.301_ref14) 1998; 160 Chapuis (10.4196/kjpp.2017.21.3.301_ref15) 1997; 27 Kim (10.4196/kjpp.2017.21.3.301_ref4) 2013; 442 Brown (10.4196/kjpp.2017.21.3.301_ref1) 1999; 142 Berliner (10.4196/kjpp.2017.21.3.301_ref2) 1995; 91 Olofsson (10.4196/kjpp.2017.21.3.301_ref11) 2008; 117 Piao (10.4196/kjpp.2017.21.3.301_ref22) 2006; 13 24954418 - Cell Metab. 2014 Jul 1;20(1):172-82 26689473 - Free Radic Biol Med. 2016 Feb;91:93-104 24482231 - J Biol Chem. 2014 Mar 7;289(10):6921-33 7729036 - Circulation. 1995 May 1;91(9):2488-96 25593648 - Biomol Ther (Seoul). 2015 Jan;23(1):84-9 9920502 - Atherosclerosis. 1999 Jan;142(1):1-28 23876312 - Biochem Biophys Res Commun. 2013 Aug 16;438(1):161-8 24269812 - Biochem Biophys Res Commun. 2013 Dec 13;442(3-4):159-64 11070085 - Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12694-9 22593212 - Mol Biol Cell. 2012 Jul;23 (13):2412-23 23760533 - Front Immunol. 2013 Jun 07;4:139 9645384 - Eur J Immunol. 1998 Jun;28(6):2025-34 25497142 - Biochim Biophys Acta. 2015 Mar;1852(3):442-50 22006022 - Mol Cell Biol. 2012 Jan;32(1):36-49 24370436 - Toxicol Appl Pharmacol. 2014 Feb 1;274(3):462-70 10837075 - Annu Rev Immunol. 2000;18:767-811 25110320 - Free Radic Biol Med. 2014 Dec;77:376-85 9045914 - Eur J Immunol. 1997 Feb;27(2):431-41 9574566 - J Immunol. 1998 May 1;160(9):4587-95 18799141 - Immunity. 2008 Sep 19;29(3):325-42 22323450 - Blood. 2012 Apr 12;119(15):3383-93 24210818 - Cell Rep. 2013 Nov 14;5(3):637-45 20458277 - Lab Invest. 2010 Jul;90(7):970-84 16733295 - J Atheroscler Thromb. 2006 Apr;13(2):82-9 18285570 - Circulation. 2008 Mar 11;117(10):1292-301 |
References_xml | – volume: 142 start-page: 1 year: 1999 ident: 10.4196/kjpp.2017.21.3.301_ref1 publication-title: Atherosclerosis doi: 10.1016/S0021-9150(98)00196-8 – volume: 5 start-page: 637 year: 2013 ident: 10.4196/kjpp.2017.21.3.301_ref8 publication-title: Cell Rep doi: 10.1016/j.celrep.2013.10.006 – volume: 23 start-page: 84 year: 2015 ident: 10.4196/kjpp.2017.21.3.301_ref12 publication-title: Biomol Ther (Seoul) doi: 10.4062/biomolther.2014.067 – volume: 77 start-page: 376 year: 2014 ident: 10.4196/kjpp.2017.21.3.301_ref9 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2014.07.026 – volume: 4 start-page: 139 year: 2013 ident: 10.4196/kjpp.2017.21.3.301_ref24 publication-title: Front Immunol doi: 10.3389/fimmu.2013.00139 – volume: 27 start-page: 431 year: 1997 ident: 10.4196/kjpp.2017.21.3.301_ref15 publication-title: Eur J Immunol doi: 10.1002/eji.1830270213 – volume: 438 start-page: 161 year: 2013 ident: 10.4196/kjpp.2017.21.3.301_ref5 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2013.07.046 – volume: 28 start-page: 2025 year: 1998 ident: 10.4196/kjpp.2017.21.3.301_ref19 publication-title: Eur J Immunol doi: 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C – volume: 23 start-page: 2412 year: 2012 ident: 10.4196/kjpp.2017.21.3.301_ref23 publication-title: Mol Biol Cell doi: 10.1091/mbc.E11-12-0993 – volume: 97 start-page: 12694 year: 2000 ident: 10.4196/kjpp.2017.21.3.301_ref20 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.97.23.12694 – volume: 442 start-page: 159 year: 2013 ident: 10.4196/kjpp.2017.21.3.301_ref4 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2013.11.052 – volume: 29 start-page: 325 year: 2008 ident: 10.4196/kjpp.2017.21.3.301_ref21 publication-title: Immunity doi: 10.1016/j.immuni.2008.08.006 – volume: 1852 start-page: 442 year: 2015 ident: 10.4196/kjpp.2017.21.3.301_ref6 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbadis.2014.12.003 – volume: 20 start-page: 172 year: 2014 ident: 10.4196/kjpp.2017.21.3.301_ref7 publication-title: Cell Metab doi: 10.1016/j.cmet.2014.05.013 – volume: 90 start-page: 970 year: 2010 ident: 10.4196/kjpp.2017.21.3.301_ref17 publication-title: Lab Invest doi: 10.1038/labinvest.2010.94 – volume: 91 start-page: 2488 year: 1995 ident: 10.4196/kjpp.2017.21.3.301_ref2 publication-title: Circulation doi: 10.1161/01.CIR.91.9.2488 – volume: 18 start-page: 767 year: 2000 ident: 10.4196/kjpp.2017.21.3.301_ref13 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.18.1.767 – volume: 32 start-page: 36 year: 2012 ident: 10.4196/kjpp.2017.21.3.301_ref18 publication-title: Mol Cell Biol doi: 10.1128/MCB.05857-11 – volume: 13 start-page: 82 year: 2006 ident: 10.4196/kjpp.2017.21.3.301_ref22 publication-title: J Atheroscler Thromb doi: 10.5551/jat.13.82 – volume: 274 start-page: 462 year: 2014 ident: 10.4196/kjpp.2017.21.3.301_ref3 publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2013.12.007 – volume: 160 start-page: 4587 year: 1998 ident: 10.4196/kjpp.2017.21.3.301_ref14 publication-title: J Immunol doi: 10.4049/jimmunol.160.9.4587 – volume: 119 start-page: 3383 year: 2012 ident: 10.4196/kjpp.2017.21.3.301_ref16 publication-title: Blood doi: 10.1182/blood-2011-11-370130 – volume: 289 start-page: 6921 year: 2014 ident: 10.4196/kjpp.2017.21.3.301_ref25 publication-title: J Biol Chem doi: 10.1074/jbc.M113.524819 – volume: 117 start-page: 1292 year: 2008 ident: 10.4196/kjpp.2017.21.3.301_ref11 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.699173 – volume: 91 start-page: 93 year: 2016 ident: 10.4196/kjpp.2017.21.3.301_ref10 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2015.12.007 – reference: 16733295 - J Atheroscler Thromb. 2006 Apr;13(2):82-9 – reference: 20458277 - Lab Invest. 2010 Jul;90(7):970-84 – reference: 25497142 - Biochim Biophys Acta. 2015 Mar;1852(3):442-50 – reference: 22323450 - Blood. 2012 Apr 12;119(15):3383-93 – reference: 10837075 - Annu Rev Immunol. 2000;18:767-811 – reference: 24269812 - Biochem Biophys Res Commun. 2013 Dec 13;442(3-4):159-64 – reference: 25593648 - Biomol Ther (Seoul). 2015 Jan;23(1):84-9 – reference: 26689473 - Free Radic Biol Med. 2016 Feb;91:93-104 – reference: 18799141 - Immunity. 2008 Sep 19;29(3):325-42 – reference: 24370436 - Toxicol Appl Pharmacol. 2014 Feb 1;274(3):462-70 – reference: 22006022 - Mol Cell Biol. 2012 Jan;32(1):36-49 – reference: 23760533 - Front Immunol. 2013 Jun 07;4:139 – reference: 23876312 - Biochem Biophys Res Commun. 2013 Aug 16;438(1):161-8 – reference: 25110320 - Free Radic Biol Med. 2014 Dec;77:376-85 – reference: 9574566 - J Immunol. 1998 May 1;160(9):4587-95 – reference: 24210818 - Cell Rep. 2013 Nov 14;5(3):637-45 – reference: 9645384 - Eur J Immunol. 1998 Jun;28(6):2025-34 – reference: 11070085 - Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12694-9 – reference: 22593212 - Mol Biol Cell. 2012 Jul;23 (13):2412-23 – reference: 24954418 - Cell Metab. 2014 Jul 1;20(1):172-82 – reference: 24482231 - J Biol Chem. 2014 Mar 7;289(10):6921-33 – reference: 9920502 - Atherosclerosis. 1999 Jan;142(1):1-28 – reference: 9045914 - Eur J Immunol. 1997 Feb;27(2):431-41 – reference: 7729036 - Circulation. 1995 May 1;91(9):2488-96 – reference: 18285570 - Circulation. 2008 Mar 11;117(10):1292-301 |
SSID | ssib008505809 ssj0064464 |
Score | 2.1012115 |
Snippet | 27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 301 |
SubjectTerms | Original 약리학 |
Title | PI3K and ERK signaling pathways are involved in differentiation of monocytic cells induced by 27-hydroxycholesterol |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28461772 https://www.proquest.com/docview/1894520450 https://pubmed.ncbi.nlm.nih.gov/PMC5409116 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002217142 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | The Korean Journal of Physiology & Pharmacology, 2017, 21(3), , pp.301-308 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKcuGCgOVRXjIIcalSGjvN47isinapQCt2VyonK3GctnRJqjYFlX_FP2TGTty0FMRySSPXmTzmy_ibyXhMyKskgEGq74dOxtPU8XiWOUmSxPBeRTyUfqq8FAP6Hz76J5fe-1F_1Gr9bGQtrcqkK3_snVfyP1qFNtArzpK9hmatUGiAfdAvbEHDsP0nHZ-d8qGO_g8-DTuYiRGbyeXA6r7H62UHs7qmORigbyrVaa_Vaijl1BJFuNZCrrFqK4bwMTkrXUnDSlngTNYpprmgidQVFYqrJplFiA2LRR3Lr3itjpWYyk4Iq_mmNraN3p-bT_2fi3w8iS2yqoWd3xaONkGbj1smm1s3do4nm0zGgQ7znisQ4wxX42YAAwZFmy5Y2VxggI7Xr7KplW5jvYg7PDRlA2pDzdwGIHnD6nIjbnc08MC6gApnX-ZYmNQNuszt8m7Vebv09s6QaBMVwUVCKQJlCJQhmCu44Dhj8CYDz0SvFjLamMgQGKWuiGbIALBNXcHM3qOZt4Uy3_x-XVvc6Ea-yPa5PbvZuw06dHGH3K78GHpkQHmXtFR-jxwe5XFZfF3T1_TMouCQLBGnFHBKAafU4pTWOKWAU1rjFHboDk5pkVGLU6pxSiuc0mRN9-L0Prl8N7g4PnGqxT4c6XG_dGKeRim4EypJQj_kbub2oiySUexFAUv81E9drpTHVBb0WIbrFvRYwDj3wQf3Ay75A3KQF7l6RGikZCxVHCsG_FjKJA7TIIwS8JyBz_akbBO3fsxCVpXwcUGWK_FndbdJxx4zN3Vg_tr7JWhPzORUYPl2_B0XYrYQ4KSeCpeD29CP2uRFrVwBNh2fXpyrYrUUbhh5fVwnotcmD42y7UmBTsLRAWuTYAsGtgOecPuffDrRdePBOQNq4z--1q08Ibc2L-1TclAuVuoZ8PAyea6R_wuy8d6z |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PI3K+and+ERK+signaling+pathways+are+involved+in+differentiation+of+monocytic+cells+induced+by+27-hydroxycholesterol&rft.jtitle=The+Korean+journal+of+physiology+%26+pharmacology&rft.au=Son%2C+Yonghae&rft.au=Kim%2C+Bo-Young&rft.au=Park%2C+Young+Chul&rft.au=Eo%2C+Seong-Kug&rft.date=2017-05-01&rft.issn=1226-4512&rft.eissn=2093-3827&rft.volume=21&rft.issue=3&rft.spage=301&rft_id=info:doi/10.4196%2Fkjpp.2017.21.3.301&rft.externalDBID=n%2Fa&rft.externalDocID=10_4196_kjpp_2017_21_3_301 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1226-4512&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1226-4512&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1226-4512&client=summon |